STERIS’ Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Further, its services ...

STERIS plc, a leading provider of infection prevention and procedural products and services for healthcare, pharmaceutical, and medical device industries, has demonstrated consistent growth and ...

Feb 5 (Reuters) - Medical equipment maker Steris (STE.N), opens new tab lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar. The Dublin-based company lowered ...

Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major ...

I reiterate a 'Hold' rating for Steris stock with a fair value of $220 per share, citing strong healthcare growth and overvaluation concerns. The divestiture of the dental business and acquisition ...

The latest price target for Steris (NYSE:STE) was reported by Morgan Stanley on May 19, 2025. The analyst firm set a price target for $260.00 expecting STE to rise to within 12 months (a possible ...

Medical equipment company Steris (NYSE: STE) plans to eliminate less than 300 positions as part of a previously announced restructuring plan. Steris said in an SEC filing last week that the move comes ...

Nov 6 (Reuters) - Medical equipment maker Steris (STE.N), opens new tab beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales ...

Steris (STE) came out with quarterly earnings of $2.74 per share, beating the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.41 per share a year ago. These figures ...